TY - JOUR
T1 - Biomarker and Pathologic Predictors of Cutaneous Squamous Cell Carcinoma Aggressiveness
AU - Khandelwal, Alok R.
AU - Ma, Xiaohui
AU - Egan, Paige
AU - Kaskas, Nadine M.
AU - Moore-Medlin, Tara
AU - Caldito, Gloria
AU - Abreo, Fleurette
AU - Gu, Xin
AU - Aubrey, Lurie
AU - Milligan, Edward
AU - Nathan, Cherie Ann O.
N1 - Publisher Copyright:
© Official journal of the American Academy of Otolaryngology-Head and Neck Surgery Foundation 2016.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Objective Aggressive cutaneous squamous cell carcinoma (cSCC) patients are at increased risk of metastasis. Currently, there are no accepted criteria or biomarkers for reliably predicting individuals at risk for recurrence and metastasis. Our objective is to determine if pS6 and pERK can predict cSCC aggressiveness and to identify primary tumor characteristics that may predict parotid metastasis. Study Design Retrospective case series. Settings Tertiary care center. Subjects and Methods An Institutional Review Board-approved retrospective review was performed for patients with facial cSCC, with and without metastasis to the parotids. Subjects for the study were identified through the Louisiana Tumor Registry, Veterans Medical Records, and LSU Health-Shreveport pathology database. Tumor specimens from patients with cSCC and cSCC with parotid metastasis were analyzed for pERK and pS6 expression through immunohistochemistry. To identify risk factors for tumor aggressiveness, multiple logistic regression analysis was used to evaluate patients with cSCC that was metastatic to the parotid and managed surgically. Results cSCC with parotid metastasis specimens exhibited significantly higher average pS6 but not pERK positivity than those from cSCC without metastasis (P <.05). Primary lesion-positive margins (P <.01), size of the skin tumor (P <.01) and degree of tumor differentiation (P <.01) were significantly associated with parotid metastasis. Conclusion Surgical history of cSCC, primary lesion-positive margins, degree of differentiation, and lesion size together with pS6 positivity appear to be predictors of cSCC aggressiveness and should prompt increased monitoring or elective parotidectomy.
AB - Objective Aggressive cutaneous squamous cell carcinoma (cSCC) patients are at increased risk of metastasis. Currently, there are no accepted criteria or biomarkers for reliably predicting individuals at risk for recurrence and metastasis. Our objective is to determine if pS6 and pERK can predict cSCC aggressiveness and to identify primary tumor characteristics that may predict parotid metastasis. Study Design Retrospective case series. Settings Tertiary care center. Subjects and Methods An Institutional Review Board-approved retrospective review was performed for patients with facial cSCC, with and without metastasis to the parotids. Subjects for the study were identified through the Louisiana Tumor Registry, Veterans Medical Records, and LSU Health-Shreveport pathology database. Tumor specimens from patients with cSCC and cSCC with parotid metastasis were analyzed for pERK and pS6 expression through immunohistochemistry. To identify risk factors for tumor aggressiveness, multiple logistic regression analysis was used to evaluate patients with cSCC that was metastatic to the parotid and managed surgically. Results cSCC with parotid metastasis specimens exhibited significantly higher average pS6 but not pERK positivity than those from cSCC without metastasis (P <.05). Primary lesion-positive margins (P <.01), size of the skin tumor (P <.01) and degree of tumor differentiation (P <.01) were significantly associated with parotid metastasis. Conclusion Surgical history of cSCC, primary lesion-positive margins, degree of differentiation, and lesion size together with pS6 positivity appear to be predictors of cSCC aggressiveness and should prompt increased monitoring or elective parotidectomy.
KW - biomarker
KW - cutaneous squamous cell carcinoma
KW - pERK
KW - ps6
UR - http://www.scopus.com/inward/record.url?scp=84980324637&partnerID=8YFLogxK
U2 - 10.1177/0194599816641913
DO - 10.1177/0194599816641913
M3 - Article
C2 - 27095050
AN - SCOPUS:84980324637
SN - 0194-5998
VL - 155
SP - 281
EP - 288
JO - Otolaryngology - Head and Neck Surgery
JF - Otolaryngology - Head and Neck Surgery
IS - 2
ER -